Relmada Therapeutics
RLMD
RLMD
113 hedge funds and large institutions have $623M invested in Relmada Therapeutics in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 97 → 113 (+16)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
39.73% less ownership
Funds ownership: 118.31% → 78.58% (-40%)
Holders
113
Holding in Top 10
3
Calls
$26.4M
Puts
$13.4M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$17.4M | |
| 3 | +$15.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.88M |
| 5 |
RI
RTW Investments
New York
|
+$9.55M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$9.01M | |
| 3 | -$8.29M | |
| 4 |
Millennium Management
New York
|
-$7.41M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$5.05M |